Patent details

Basic Information

Publication number:

EP3485903

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP181973389

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

French Title of Invention:

AGENTS DE LIAISON À VEGF/DLL4 ET LEURS UTILISATIONS

German Title of Invention:

VEGF/DLL4-BINDENDE STOFFE UND IHRE VERWENDUNG

SPC Number:

Dates

Filing date:

24/09/2012

Grant date:

16/11/2022

EP Publication Date:

22/05/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/11/2022

EP B1 Publication Date:

16/11/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

24/09/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/02/2023

 

 

Name:

Mereo BioPharma 5, Inc.

Address:

800 W El Camino Real Suite 180, Mountain View, CA 94040, United States (US)

History of Owners

From:

09/02/2023

To:

03/02/2023

Name:

MEREO BIOPHARMA 5, INC.

Address:

800 W El Camino Real, Suite 180, CA 94040, Mountain View, California, United States (US)

From:

09/11/2022

To:

09/02/2023

Name:

Mereo BioPharma 5, Inc.

Address:

800 Chesapeake Drive, Redwood City, CA 94063-4748, United States (US)

Agent

Name:

COSMOVICI INTELLECTUAL PROPERTY SARL

From:

09/02/2023

Address:

11, Boulevard Sébastopol, 75001, Paris, France (FR)

To:

Inventor

1

Name:

GURNEY, Austin L.

Address:

United States (US)

2

Name:

BOND, Christopher John

Address:

United States (US)

3

Name:

SATO, Aaron Ken

Address:

United States (US)

Priority

1

Priority Number:

201161538454 P

Priority Date:

23/09/2011

Priority Country:

United States (US)

2

Priority Number:

201261597409 P

Priority Date:

10/02/2012

Priority Country:

United States (US)

3

Priority Number:

201261692978 P

Priority Date:

24/08/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/00; C12P 21/08; C07K 16/00; A61P 35/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/03

Publication date:

01/03/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202246

Publication date:

16/11/2022

Description:

Grant (B1)

2

Issue number:

202310

Publication date:

08/03/2023

Description:

Change of owner's name or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20230000052A

Date Registered:

09/02/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

COSMOVICI INTELLECTUAL PROPERTY SARL

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

MEREO BIOPHARMA 5, INC.

Address:

800 W El Camino Real, Suite 180, CA 94040, Mountain View, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2025

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

09/08/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
09/02/2023	Power Of Attorney	2
09/02/2023	Request For Change	8
10/02/2023	Outgoing Correspondence	1
10/02/2023	Outgoing Correspondence	1